Cytiva Completes $1.6 Billion in Strategic Investments to Further Enhance Global Supply Chain

Cytiva Completes $1.6 billion in Strategic Investments to Further Enhance Global Supply Chain

Officials at Cytiva report that the company has completed significant expansion projects in several locations in the U.S., Europe, and Asia as part of its ongoing commitment to customers developing and manufacturing advanced therapeutics. Set to continue through 2028, these expansions will meet increased customer demand as part of Cytiva’s long-term growth plan and in-region manufacturing strategy, supported by an investment of $1.6 billion sinc…

Cytiva outlines $1.6bn facility investment plans through 2028

The strategic investment prioritizing chromatography resins and filtration lines enhances capabilities across North America, Europe, and Asia-Pacific regions to strengthen biopharmaceutical supply chains and accelerate therapy development worldwide.